Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

琥乙红霉素颗粒 - NMPA Drug Approval Details

Approvals/NMPA/Erythromycin Ethylsuccinate Granules

Approved

化学药品

Erythromycin Ethylsuccinate Granules

纽哈伯药业有限公司🇨🇳 National Medical Products Administration

Approval Date: Sep 13, 2002
Approval ID: 7zyyIMFmIDA
Company: 纽哈伯药业有限公司
Type: 化学药品

Approval Details

Approval Id: 7zyyIMFmIDA
Approval Number: 国药准字H19994113
Generic Name: 琥乙红霉素颗粒
Generic Name En: Erythromycin Ethylsuccinate Granules
Drug Type: 化学药品
Dosage Form: 颗粒剂
Strength: 按C37H67NO13计0.125g(12.5万单位)
Reg Date: 2002-09-13
Company Name: 纽哈伯药业有限公司
Production Company Address: 河北省三河市燕郊经济开发区工业大道
Company Detail Path: /organization/niu-ha-bo-yao-ye-you-xian-gong-si

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Sep 13, 2002

Approval ID

7zyyIMFmIDA

Type

化学药品

Back to NMPA Approvals